Nalorphine
| Internal ID | b3ca8761-af39-4d7d-b5ba-7bb752ad335f |
| Taxonomy | Alkaloids and derivatives > Morphinans |
| IUPAC Name | (4R,4aR,7S,7aR,12bS)-3-prop-2-enyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C19H21NO3/c1-2-8-20-9-7-19-12-4-6-15(22)18(19)23-17-14(21)5-3-11(16(17)19)10-13(12)20/h2-6,12-13,15,18,21-22H,1,7-10H2/t12-,13+,15-,18-,19-/m0/s1 |
| InChI Key | UIQMVEYFGZJHCZ-SSTWWWIQSA-N |
| Popularity | 2,387 references in papers |
| Molecular Formula | C19H21NO3 |
| Molecular Weight | 311.40 g/mol |
| Exact Mass | 311.15214353 g/mol |
| Topological Polar Surface Area (TPSA) | 52.90 Ų |
| XlogP | 1.90 |
| Atomic LogP (AlogP) | 1.75 |
| H-Bond Acceptor | 4 |
| H-Bond Donor | 2 |
| Rotatable Bonds | 2 |
| Nalorfina |
| N-Allylnormorphine |
| 62-67-9 |
| Nalorphinum |
| Allylnormorphine |
| Nalorphine serb |
| Normorphine, N-allyl- |
| N-Allyl-N-desmethylmorphine |
| U59WB2WRY2 |
| NANM |
| There are more than 10 synonyms. If you wish to see them all click here. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9561 | 95.61% |
| Caco-2 | + | 0.6452 | 64.52% |
| Blood Brain Barrier | + | 1.0000 | 100.00% |
| Human oral bioavailability | - | 0.8571 | 85.71% |
| Subcellular localzation | Mitochondria | 0.6734 | 67.34% |
| OATP2B1 inhibitior | - | 0.8615 | 86.15% |
| OATP1B1 inhibitior | + | 0.9293 | 92.93% |
| OATP1B3 inhibitior | + | 0.9486 | 94.86% |
| MATE1 inhibitior | - | 1.0000 | 100.00% |
| OCT2 inhibitior | - | 0.7500 | 75.00% |
| BSEP inhibitior | - | 0.8742 | 87.42% |
| P-glycoprotein inhibitior | - | 0.8290 | 82.90% |
| P-glycoprotein substrate | + | 0.7948 | 79.48% |
| CYP3A4 substrate | + | 0.6866 | 68.66% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | + | 0.6725 | 67.25% |
| CYP3A4 inhibition | - | 0.8521 | 85.21% |
| CYP2C9 inhibition | - | 0.9068 | 90.68% |
| CYP2C19 inhibition | - | 0.8442 | 84.42% |
| CYP2D6 inhibition | - | 0.6001 | 60.01% |
| CYP1A2 inhibition | - | 0.5841 | 58.41% |
| CYP2C8 inhibition | - | 0.8838 | 88.38% |
| CYP inhibitory promiscuity | - | 0.6184 | 61.84% |
| UGT catelyzed | + | 0.9000 | 90.00% |
| Carcinogenicity (binary) | - | 0.9700 | 97.00% |
| Carcinogenicity (trinary) | Non-required | 0.5835 | 58.35% |
| Eye corrosion | - | 0.9893 | 98.93% |
| Eye irritation | - | 0.9779 | 97.79% |
| Skin irritation | - | 0.7492 | 74.92% |
| Skin corrosion | - | 0.9126 | 91.26% |
| Ames mutagenesis | - | 0.7000 | 70.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.6528 | 65.28% |
| Micronuclear | + | 0.5600 | 56.00% |
| Hepatotoxicity | - | 0.7625 | 76.25% |
| skin sensitisation | - | 0.7556 | 75.56% |
| Respiratory toxicity | + | 0.9333 | 93.33% |
| Reproductive toxicity | + | 0.8778 | 87.78% |
| Mitochondrial toxicity | + | 0.9875 | 98.75% |
| Nephrotoxicity | - | 0.8371 | 83.71% |
| Acute Oral Toxicity (c) | III | 0.5530 | 55.30% |
| Estrogen receptor binding | - | 0.6700 | 67.00% |
| Androgen receptor binding | - | 0.8512 | 85.12% |
| Thyroid receptor binding | + | 0.6238 | 62.38% |
| Glucocorticoid receptor binding | + | 0.5758 | 57.58% |
| Aromatase binding | - | 0.6702 | 67.02% |
| PPAR gamma | + | 0.6551 | 65.51% |
| Honey bee toxicity | - | 0.7234 | 72.34% |
| Biodegradation | - | 0.9250 | 92.50% |
| Crustacea aquatic toxicity | - | 0.5300 | 53.00% |
| Fish aquatic toxicity | + | 0.8096 | 80.96% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| CHEMBL236 | P41143 | Delta opioid receptor |
120 nM 120 nM |
Ki Ki |
via Super-PRED
PMID: 19027293 |
| CHEMBL237 | P41145 | Kappa opioid receptor |
2 nM 0.38 nM 0.38 nM |
Ki Ki Ki |
PMID: 26390077
via Super-PRED PMID: 19027293 |
| CHEMBL233 | P35372 | Mu opioid receptor |
0.36 nM 0.19 nM 0.19 nM |
Ki Ki Ki |
PMID: 26390077
via Super-PRED PMID: 19027293 |
| CHEMBL287 | Q99720 | Sigma opioid receptor |
735 nM 1800 nM 2850 nM 4000 nM 48 nM 93 nM 625 nM |
IC50 IC50 IC50 IC50 IC50 IC50 IC50 |
PMID: 1469697
PMID: 1469697 PMID: 1469697 PMID: 1469697 PMID: 1469697 PMID: 1469697 PMID: 1469697 |
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.04% | 96.09% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.95% | 91.11% |
| CHEMBL5697 | Q9GZT9 | Egl nine homolog 1 | 94.83% | 93.40% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.21% | 94.45% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 90.73% | 95.89% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 85.61% | 95.56% |
| CHEMBL3492 | P49721 | Proteasome Macropain subunit | 84.02% | 90.24% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 83.90% | 100.00% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 83.29% | 86.33% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 83.13% | 97.09% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 83.07% | 100.00% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 82.25% | 91.03% |
| CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 81.91% | 89.62% |
| CHEMBL238 | Q01959 | Dopamine transporter | 81.14% | 95.88% |
| CHEMBL4829 | O00763 | Acetyl-CoA carboxylase 2 | 80.57% | 98.00% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 80.29% | 93.04% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Papaver somniferum |
| PubChem | 5284595 |
| NPASS | NPC243483 |
| ChEMBL | CHEMBL415284 |
| LOTUS | LTS0175846 |
| wikiData | Q2622916 |